Denise L.  Devine net worth and biography

Denise Devine Biography and Net Worth

Director of SelectQuote
Denise Devine was appointed to serve as a director of SelectQuote in February 2020. Ms. Devine is the founder of FNB Holdings, LLC—a company dedicated to initiatives in the health and wellness space and has served as the company’s CEO since 2008. She is also a founder of early stage medical device company, RTM Vital Signs, and has also served as the CFO since 2014. Ms. Devine also founded and served as the CEO from 1994 to 2006 of Nutripharm, Inc., a company that has generated a portfolio of composition and process patents to create innovative natural food, beverage, pharmaceutical and nutraceutical products. A Certified Public Accountant, Ms. Devine also previously served as CFO of Energy Solutions International from 2006 to 2008. She has served as a member of the Board of Ben Franklin Technology Partners of Southeastern Pennsylvania since 2016 and was appointed to the Board of Ben Franklin Technology Development Authority in 2018. Ms. Devine has served as a director of Fulton Financial Corporation since 2012, AgroFresh Solutions, Inc. since 2018 and Cubic Corporation since 2019. Ms. Devine received her Master of Business Administration from The Wharton School at the University of Pennsylvania, her Masters in Taxation from Villanova Law School and her undergraduate degree in Accounting from Villanova University.

How do I contact Denise L. Devine?

The corporate mailing address for Ms. Devine and other SelectQuote executives is 6800 WEST 115TH STREET SUITE 2511, OVERLAND PARK KS, 66211. SelectQuote can also be reached via phone at 913-599-9225 and via email at [email protected]. Learn More on Denise L. Devine's contact information.

Has Denise L. Devine been buying or selling shares of SelectQuote?

Denise L. Devine has not been actively trading shares of SelectQuote in the last ninety days. Learn More on Denise L. Devine's trading history.

Who are SelectQuote's active insiders?

SelectQuote's insider roster includes Timothy Danker (CEO), Earl Devanny, III (Director), Denise Devine (Director), Robert Grant (Insider), William Grant, III (COO), Donald Hawks, III (Director), and Raffaele Sadun (Insider). Learn More on SelectQuote's active insiders.

Denise L. Devine Insider Trading History at SelectQuote

See Full Table

Denise L. Devine Buying and Selling Activity at SelectQuote

This chart shows Denise L. Devine's buying and selling at SelectQuote by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

SelectQuote Company Overview

SelectQuote logo
SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies. The company also provides SelectRx, an accredited patient-centered pharmacy home pharmacy, which offers essential prescription medications, OTC medications, customized medication packaging, medication therapy management, and long-term pharmacy care; and population health that helps members understand the benefits available under their health plans, and contracts with insurance carriers. SelectQuote, Inc. was incorporated in 1999 and is headquartered in Overland Park, Kansas.
Read More

Today's Range

Now: $2.45
Low: $2.43
High: $2.57

50 Day Range

MA: $2.22
Low: $1.83
High: $3.59

2 Week Range

Now: $2.45
Low: $1.03
High: $4.46

Volume

586,501 shs

Average Volume

1,254,545 shs

Market Capitalization

$420.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.06